Tuberculosis mutation discovery could lead to better treatments
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
List view / Grid view
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
The novel method for imaging molecules in cells and tissue samples, called DNA microscopy, could improve knowledge of disease development.
The UK Brain Banks Network has been enhanced to include genomic data, which can be accessed by researchers worldwide.
A research team has found that blocking a particular kinase in a mouse model of arrhythmogenic cardiomyopathy led to improved survival rates.
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
An algorithm has been developed which can predict the outcomes of complex chemical reactions with over 90 percent accuracy which can be applied to drug development.
Researchers have mapped a previously uncharted region of the human genome which could lead to tests for certain conditions in the future.
Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
A new study has demonstrated the possibility of treating antibiotic-resistant Pseudomonas aeruginosa which causes sepsis in burn patients.
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
A team from MIT sequenced bacteria samples from the digestive system which can be accessed by researchers to use in the development of treatments.
The British Journal of Pharmacology has recommended that all studies it publishes should address sex as an experimental variable.
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.